Royal Bank of Canada »

Kairos Pharma shares owned by Royal Bank of Canada

Quarter-by-quarter ownership of Kairos Pharma (KAPA) shares owned by Royal Bank of Canada from 13F filings

Historical chart of Royal Bank of Canada investment in Kairos Pharma

Tip: Access up to 7 years of quarterly data

All positions including Kairos Pharma held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kairos Pharma by Royal Bank of Canada

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.0k 1.0k 1.00

More positions owned by Royal Bank of Canada

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Amazon (AMZN)
Toronto Dominion Bk Ont Com New (TD)
Rbc Cad (RY)
Bank Of Montreal Cadcom (BMO)
Bk Nova Cad (BNS)
Alphabet Cap Stk Cl A (GOOGL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
JPMorgan Chase & Co. (JPM)
Broadcom (AVGO)
Ishares Tr Russell 2000 Etf (IWM)

View all positions for Royal Bank of Canada

Top funds holding Kairos Pharma

Vanguard Group
Geode Capital Management
Two Sigma Investments
Aptus Capital Advisors
SevenBridge Financial
Two Sigma Securities
State Street Corporation
XTX Topco
UBS Group
Tower Research Capital
Royal Bank of Canada

View all funds holding Kairos Pharma